報價延遲最少15分鐘:2025/04/12 04:11 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
15.9 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-2.34/-1.56
|
|
企業價值
865.17M
|
| 資產負債 |
|
每股賬面淨值
15.08
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/04/12 04:11 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leveragesboth structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable andoperating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs. |